Product Information
CLOBETASOL PROP 0.05% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3045 per GM under NDC 45802043733. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 10, 2008. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Clobetasol propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802043733
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA077763FDA Approved
3/10/2008
TE Code
AB1
On Market Since
3/20/2008
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL PROP 0.05% FOAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 86.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3045 per GM |
|---|---|
| All-time high | $4.7346 (Dec 16, 2015) |
| All-time low | $0.2903 (Jan 21, 2026) |
| 52-week high | $0.3482 |
| 52-week low | $0.2903 |
| Median price | $1.4548 |
| Average price | $1.9993 |
| Largest weekly change | +59.9% (Jun 19, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobetasol propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL PROP 0.05% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL PROP 0.05% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3045 per GM (NDC 45802043733), effective Sep 30, 2026.
How has the price of CLOBETASOL PROP 0.05% FOAM changed over time?
Over the history we have for it, the NADAC for CLOBETASOL PROP 0.05% FOAM has declined 86.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOBETASOL PROP 0.05% FOAM?
Since Nov 28, 2013, the NADAC for CLOBETASOL PROP 0.05% FOAM has ranged from a low of $0.2903 (Jan 21, 2026) to a high of $4.7346 (Dec 16, 2015), with a median of $1.4548 per GM.
Are there cheaper alternatives to CLOBETASOL PROP 0.05% FOAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOBETASOL PROP 0.05% FOAM in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBETASOL PROP 0.05% FOAM?
CLOBETASOL PROP 0.05% FOAM (NDC 45802043733) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.